Evidence for efficacy is based on the results from the LIBRETTO-531 study
Home World News FDA Grants Traditional Approval for Selpercatinib for Medullary Thyroid Cancer with a...
Evidence for efficacy is based on the results from the LIBRETTO-531 study
